C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia

Table 5

Baseline characteristics of ARVD/C and documented VT patients with or without CRP level measured within the 24 hours following VT.

	CRP < 24 h (𝑛=17) Mean ± SD	CRP > 24 h (𝑛=29) Mean ± SD	𝑃 value
Age (years)	44 ± 18	37 ± 13	.196
Male (%)	88	86	.998
Hypertension (%)	20	45	.283
Hypercholesterolemia (%)	27	9	.198
Smokers (%)	20	10	.630
RV dysfunction (%)	31	21	.698
Statin (%)	12	3	.285
Aspirin (%)	6	3	.998
VT-R	188 ± 41/min	201 ± 51/min	.552

ARVD/C, Arrhythmogenic right ventricular dysplasia/cardiomyopathy; RVOT, Right ventricular outflow tract; RV, Right ventricular; VT, Ventricular tachycardia; VT-R, Ventricular tachycardia rate; ICD, Implantable cardioverter-defibrillator; CRP, C-reactive protein.